Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute exacerbation of idiopathic pulmonary fibrosis.
Fidler L, Shapera S. Fidler L, et al. Among authors: shapera s. Can Respir J. 2015 Nov-Dec;22(6):308. doi: 10.1155/2015/479467. Epub 2015 Jul 7. Can Respir J. 2015. PMID: 26151836 Free PMC article. No abstract available.
Idiopathic Pulmonary Fibrosis: A Review of Disease, Pharmacological, and Nonpharmacological Strategies With a Focus on Symptoms, Function, and Health-Related Quality of Life.
Rozenberg D, Sitzer N, Porter S, Weiss A, Colman R, Reid WD, Shapera S, Fisher J, Wentlandt K. Rozenberg D, et al. Among authors: shapera s. J Pain Symptom Manage. 2020 Jun;59(6):1362-1378. doi: 10.1016/j.jpainsymman.2019.12.364. Epub 2019 Dec 28. J Pain Symptom Manage. 2020. PMID: 31887400 Free article. Review.
What's your call? Drop metastases.
Choi PP, Shapera S. Choi PP, et al. Among authors: shapera s. CMAJ. 2006 Aug 29;175(5):475, 477. doi: 10.1503/cmaj.060308. CMAJ. 2006. PMID: 16940262 Free PMC article. No abstract available.
The CAnadian REgistry for Pulmonary Fibrosis (CARE-PF): Design and rationale of a national pulmonary fibrosis registry.
Ryerson CJ, Tan B, Fell CD, Manganas H, Shapera S, Mittoo S, Sadatsafavi M, To T, Gershon A, Fisher JH, Johannson KA, Hambly N, Khalil N, Marras TK, Morisset J, Wilcox PG, Halayko AJ, Khan MA, Kolb M. Ryerson CJ, et al. Among authors: shapera s. Can Respir J. 2015 Nov 2:17206. Online ahead of print. Can Respir J. 2015. PMID: 26523546 No abstract available.
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M; INBUILD trial investigators. Wells AU, et al. Lancet Respir Med. 2020 May;8(5):453-460. doi: 10.1016/S2213-2600(20)30036-9. Epub 2020 Mar 5. Lancet Respir Med. 2020. PMID: 32145830 Clinical Trial.
What to do with all of these lung nodules?
Rozenberg D, Shapera S. Rozenberg D, et al. Among authors: shapera s. Can Respir J. 2014 May-Jun;21(3):e52-4. doi: 10.1155/2014/593430. Can Respir J. 2014. PMID: 24914609 Free PMC article.
66 results